VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,855 | -61.8% | 198 | 0.0% | 0.00% | – |
| Q2 2023 | $4,857 | +22.8% | 198 | +16.5% | 0.00% | – |
| Q1 2023 | $3,956 | -100.0% | 170 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $27,825,662 | +695541.6% | 1,099,394 | +538818.6% | 0.14% | – |
| Q3 2022 | $4,000 | -100.0% | 204 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $19,979,000 | +285314.3% | 784,411 | +288286.4% | 0.15% | – |
| Q1 2022 | $7,000 | -50.0% | 272 | -19.8% | 0.00% | – |
| Q4 2021 | $14,000 | +75.0% | 339 | +86.3% | 0.00% | – |
| Q3 2021 | $8,000 | -11.1% | 182 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -89.9% | 182 | -89.5% | 0.00% | -100.0% |
| Q1 2021 | $89,000 | -23.9% | 1,739 | -60.3% | 0.00% | 0.0% |
| Q4 2020 | $117,000 | +1850.0% | 4,378 | +2445.3% | 0.00% | – |
| Q3 2020 | $6,000 | +50.0% | 172 | +100.0% | 0.00% | – |
| Q2 2020 | $4,000 | – | 86 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |